Compositions and methods for eliciting an in vivo cytotoxic lymphocyte
(CTL) response against a modified soluble protein antigen are disclosed.
The modified soluble protein antigen comprises an added peptidic sequence
which facilitates entry of the modified antigen into antigen presenting
cells (APC).